A stool test may be the next wellness battleground. Resbiotic and Tiny Health want in early
Find out how Resbiotic and Tiny Health’s at-home microbiome test could reshape consumer gut health, diagnostics and personalised wellness.
OLLY launches Precise Probiotics: Is targeted gut health the next big wellness trend
Explore how OLLY’s Precise Probiotics could reshape gut health trends and personalized wellness. Find out what this means for consumers today.
How Sōlaria Biō is positioning Bōndia for credibility in a crowded bone health market
Sōlaria Biō validates gut delivery and control of Bōndia microbes. Read what the study really means for bone health and medical foods.
MH002 enters phase 2b: Can MRM Health’s live biotherapeutic consortium redefine ulcerative colitis treatment standards?
MRM Health’s MH002 enters phase 2b for ulcerative colitis. Can this live biotherapeutic redefine immune-sparing treatment in IBD? Find out what’s at stake.